The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment - Concepedia

Concepedia

Publication | Open Access

The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment

DOI Full Paper Access

55

Citations

28

References

2012

Year

Hong Zhou, Sühendan Ekmekçioglu, John W. Marks, Khalid A. Mohamedali, Kaushal Asrani, Keeley Phillips, Sharron A.N. Brown, Emily H. Cheng, Michele B. Weiss, Walter N. Hittelman,

Journal of Investigative Dermatology

Tweak Receptor Fn14MelanomaImmunologyMalignant Melanoma TreatmentImmune Checkpoint InhibitorFn14 ReceptorImmunotherapyMedicineCell BiologySkin Cancer

References

	Year	Citations

Page 1

Page 1